Minori Rosales
Chief Tech/Sci/R&D Officer at COMPASS THERAPEUTICS, INC.
Minori Rosales active positions
| Companies | Position | Start | End |
|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-04-30 | - |
Career history of Minori Rosales
Former positions of Minori Rosales
| Companies | Position | Start | End |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-12-31 | 2023-04-30 |
| MACROGENICS, INC. | Chief Tech/Sci/R&D Officer | 2018-09-30 | 2021-12-31 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2017-09-30 | 2017-12-31 |
Training of Minori Rosales
| Yamaguchi University | Doctorate Degree |
| Kansai Medical University | Doctorate Degree |
Statistics
International
| United States | 5 |
| Japan | 3 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MACROGENICS, INC. | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Minori Rosales
- Experience
